26450 articles – 20328 references  [version française]
Detailed view Conference proceedings
Risk management for analytical methods: conciliating objectives of methods, validation phase and routine decision rules., France (2005)
Attached file list to this document: 
PDF
Maumy_risk_management_texte.pdf(100.5 KB)
Risk management for analytical methods: conciliating objectives of methods, validation phase and routine decision rules.
Myriam Maumy1, B. Boulanger, W. Dewe, A. Gilbert, B. Govaerts.

In the industries that involved either chemistry or biology, such as pharmaceutical industries, chemical industries or food industry, the analytical methods are the necessary eyes and hear of all the material produced or used. If the quality of an analytical method is doubtful, then the whole set of decision that will be based on those measures is questionable. For those reasons, being able to assess the quality of an analytical method is far more than a statistical challenge; it's a matter of ethic and good business practices. Many regulatory documents have been releases, primarily ICH and FDA documents in the pharmaceutical industry (FDA, 1995, 1997, 2001) to address that issue.
1:  IRMA - Institut de Recherche Mathématique Avancée